Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01964
Species: Homo sapiens
Position : chr5:149631000-149636000
Year: 2022
Title: TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  34718356
MONDO: MONDO:0004989
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: Human breast cancer cell
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq; RNA-seq; DNase-seq
Low Throughput Method: Luciferase Reporter Assay; ChIP-RT-qPCR; CRISPR knockout; RT-RT-qPCR; Western blot
About Target Gene
Target gene : TCOF1
About TF
TF name : YY1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
YY1 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
YY1 DNA Damage Recognition in GG-NER reactome 38
YY1 E2F transcription factor network pid 77
YY1 mTOR signaling pathway pid 66
YY1 Notch-mediated HES/HEY network pid 48
YY1 Notch netpath 76
YY1 Notch signaling pathway pid 58
YY1 p53 pathway pid 59
YY1 Signaling events mediated by HDAC Class I pid 89
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_01961 chr5:149631000-149636000 breast malignant cell breast carcinoma
E_01962 chr5:149631000-149636000 breast malignant cell breast carcinoma
E_01963 chr5:149631000-149636000 breast malignant cell breast carcinoma
Expression of Target Genes for the Enhancer